| Safety of Vonoprazan-Amoxicillin Dual Therapy Versus Concomitant Quadruple Therapy for H. Pylori Eradication | Vonoprazan, Omeprazole | Phase 4 | Recruiting | Ignacio Moratorio | Nov 9, 2026 |
| An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates | Omeprazole | Phase 1 | Not yet recruiting | Sanofi | Nov 6, 2026 |
| Efficacy and Safety of K-CAB(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD | Tegoprazan | — | Recruiting | HK inno.N Corporation | Nov 6, 2026 |
| A Study of Imlunestrant (LY3484356) in Healthy Female Participants | Omeprazole | Phase 1 | Not yet recruiting | Eli Lilly and Company | Nov 5, 2026 |
| Prophylactic PPI Use After EUS-GE Procedure | Esomeprazole, Omeprazole | Not applicable | Not yet recruiting | Changhai Hospital | Oct 27, 2026 |
| Efficacy and Safety of Linarazen Gluconate Capsules Combined With Amoxicillin (Dual-Drug Therapy) Versus Bismuth-Containing Quadruple Therapy for First-Line Eradication of Helicobacter Pylori Infection | Esomeprazole | Phase 4 | Recruiting | Yongquan Shi | Oct 27, 2026 |
| Assessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21) | Rabeprazole | Phase 1 | Recruiting | Dizal Pharmaceuticals | Oct 22, 2026 |
| A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS). | Omeprazole | Phase 1 | Not yet recruiting | Eli Lilly and Company | Oct 20, 2026 |
| A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult Subjects | Omeprazole | Phase 1 | Recruiting | Basilea Pharmaceutica | Oct 19, 2026 |
| Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive Subjects | Dexlansoprazole, Lansoprazole | Phase 3 | Not yet recruiting | Onconic Therapeutics Inc. | Oct 15, 2026 |
| A Phase I Study of the Interaction of D-2570 With Other Drugs in Healthy Adults | Omeprazole | Phase 1 | Not yet recruiting | InventisBio Co., Ltd | Oct 15, 2026 |
| A Study to Investigate the Effect of Omeprazole and Cyclosporine on Velzatinib in Healthy Participants | Omeprazole | Phase 1 | Not yet recruiting | GlaxoSmithKline | Oct 7, 2026 |
| Vonoprazan-Amoxicillin Dual Therapy for Helicobacter Pylori Infection in United States Adolescents | Vonoprazan | Phase 2 | Not yet recruiting | Boston Children's Hospital | Oct 6, 2026 |
| Efficacy and Safety of Second-Line Helicobacter Pylori Eradication | Esomeprazole, Tegoprazan | Not applicable | Active, not recruiting | Seoul National University Bundang Hospital | Oct 2, 2026 |
| Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male Volunteers | Tegoprazan | Phase 1 | Not yet recruiting | HK inno.N Corporation | Oct 1, 2026 |
| PPI Dosing Per CYP2C19 Genotype | Pantoprazole | Phase 4 | Recruiting | University of Florida | Sep 28, 2026 |
| Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori Infection | Esomeprazole | Not applicable | Not yet recruiting | Anabio R&D | Sep 18, 2026 |
| A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD | Tegoprazan | Phase 4 | Not yet recruiting | HK inno.N Corporation | Sep 17, 2026 |
| A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants | Pantoprazole | Phase 1 | Recruiting | Bristol-Myers Squibb | Sep 2, 2026 |
| A Study of RO7890597 in Healthy Adult Volunteers | Rabeprazole | Phase 1 | Recruiting | Genentech, Inc. | Sep 1, 2026 |
| GMPA Versus PPI for Gastric Protection and aGVHD Risk | Esomeprazole | Not applicable | Recruiting | First Affiliated Hospital of Zhejiang University | Aug 28, 2026 |
| Mirgeal® Gel as Add-on Therapy to Esomeprazole in Adults With Non-Erosive Gastroesophageal Reflux Disease | Esomeprazole | Not applicable | Not yet recruiting | Liaquat University of Medical & Health Sciences | Aug 27, 2026 |
| Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori Infection | Rabeprazole | Not applicable | Not yet recruiting | Chih-An Shih, MD | Aug 26, 2026 |
| Keverprazan vs Pantoprazole for the Treatment of ANVUGIB | Pantoprazole | Not applicable | Not yet recruiting | General Hospital of Shenyang Military Region | Aug 20, 2026 |
| Potassium-competitive Acid Blocker Versus Double Dose Proton Pump Inhibitors in High High-risk Peptic Ulcer Bleeding | Esomeprazole | Not applicable | Not yet recruiting | National Cheng-Kung University Hospital | Aug 19, 2026 |
| Efficacy and Safety of 14-Day Vonoprazan-Minocycline Dual Therapy for Helicobacter Pylori Eradication | Vonoprazan | Phase 4 | Not yet recruiting | Qilu Hospital of Shandong University | Aug 11, 2026 |
| A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks | Vonoprazan | Phase 3 | Recruiting | Phathom Pharmaceuticals, Inc. | Aug 7, 2026 |
| Assessing the Role of Proton Pump Inhibitors in Reducing Aspiration Incidence in Pediatric Laryngomalacia Cases | Esomeprazole | Not applicable | Recruiting | Minia University | Aug 6, 2026 |
| Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis | Abeprazan | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | Aug 5, 2026 |
| Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors | Pantoprazole | Not applicable | Recruiting | Alexandria University | Aug 4, 2026 |
| Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer | Dexlansoprazole, Lansoprazole, Abeprazan | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | Jul 28, 2026 |
| Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis | Dexlansoprazole, Lansoprazole | Phase 3 | Not yet recruiting | Onconic Therapeutics Inc. | Jul 28, 2026 |
| Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial | Vonoprazan | Not applicable | Recruiting | Asian Institute of Gastroenterology, India | Jul 28, 2026 |
| Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A Multicenter Non-Inferiority Randomized Controlled Trial | Vonoprazan | Phase 4 | Not yet recruiting | Shandong University | Jul 22, 2026 |
| A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults | Vonoprazan, Abeprazan | Phase 1 | Not yet recruiting | Addpharma Inc. | Jul 21, 2026 |
| Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic Ulcers | Dexlansoprazole, Lansoprazole, Tegoprazan | Phase 2 | Recruiting | Universitas Indonesia | Jul 16, 2026 |
| Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms | Vonoprazan | Not applicable | Enrolling by invitation | Mahidol University | Jul 16, 2026 |
| Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) | Tegoprazan | Phase 3 | Recruiting | Hanyang University Guri Hospital | Jul 7, 2026 |
| A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants | Pantoprazole | Phase 1 | Not yet recruiting | Chiesi Farmaceutici S.p.A. | Jul 6, 2026 |
| An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients | Tegoprazan | — | Recruiting | HK inno.N Corporation | Jul 1, 2026 |
| Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease | Dexlansoprazole, Lansoprazole, Pantoprazole, Rabeprazole | Phase 4 | Not yet recruiting | University of Mons | May 28, 2026 |
| Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets | Rabeprazole | Phase 1 | Active, not recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | May 27, 2026 |
| Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With Cirrhosis | Rabeprazole | Phase 3 | Not yet recruiting | King George's Medical University | May 27, 2026 |
| Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication | Dexlansoprazole, Lansoprazole | Not applicable | Not yet recruiting | University of Health Sciences Lahore | May 8, 2026 |
| Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | Abeprazan | — | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | Apr 30, 2026 |
| Paracetamol and Ibuprofen With or Without Famotidine for Calcific Tendinitis of the Shoulder | Pantoprazole | Not applicable | Not yet recruiting | University Hospital Dubrava | Apr 20, 2026 |
| Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer | Dexlansoprazole, Lansoprazole, Abeprazan | Phase 4 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | Apr 16, 2026 |
| FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants) | Abeprazan | Not applicable | Not yet recruiting | Ewha Womans University Mokdong Hospital | Mar 27, 2026 |
| Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy | Dexlansoprazole, Lansoprazole, Abeprazan | Not applicable | Recruiting | SUK MIN SEO | Mar 18, 2026 |
| Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention | Rabeprazole | Phase 4 | Recruiting | Yonsei University | Mar 13, 2026 |
| Fecal Molecular Susceptibility-guided Hp Rescue Therapy | Tegoprazan | Phase 4 | Not yet recruiting | Shanghai Zhongshan Hospital | Feb 12, 2026 |
| Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy | Rabeprazole | Not applicable | Recruiting | Kaohsiung Medical University | Jan 22, 2026 |
| Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection | Pantoprazole | Phase 2 | Recruiting | Tanta University | Dec 19, 2025 |
| Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis | Abeprazan | — | Recruiting | Daewoong Pharmaceutical Co. LTD. | Apr 29, 2025 |
| Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer | Ilaprazole | Phase 3 | Active, not recruiting | Il-Yang Pharm. Co., Ltd. | Feb 29, 2024 |
| Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding | Ilaprazole | Phase 4 | Not yet recruiting | West China Hospital | Nov 22, 2022 |